サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1505193

全ゲノム増幅の世界市場：2024年～2031年

Global Whole Genome Amplification Market 2024-2031

出版日
ページ情報
英文 130 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
全ゲノム増幅の世界市場：2024年～2031年
出版日: 2024年06月26日
発行: Orion Market Research
ページ情報: 英文 130 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

全ゲノム増幅市場は予測期間（2024-2031年）にCAGR 7.3％で成長すると予測されます。全ゲノム増幅は、ナノグラム量のDNAからマイクログラム量の増幅産物まで、全ゲノムを増幅するプロセスです。単一のDNA細胞から材料を増幅するために使用されており、DNA産物の少量サンプルを保存するための重要なツールです。プライマー伸長前増幅、多重置換増幅、縮退オリゴヌクレオチドPCRなど、数多くの技術が全ゲノム増幅のために開発されています。

市場力学

遺伝子検査における研究開発需要の高まり

市場拡大の主な要因の一つは、遺伝子検査、ゲノミクス、生物学的研究、分子診断の分野における研究開発への要求の高まりです。2024年1月、精密医療研究を加速させるソフトウェア企業Sano Geneticsは、MMC Ventures、Episode 1、Seedcampなどの既存投資家の参加を得て、Pluralが主導する形で1,140万米ドルの新規資金を調達しました。遺伝子検査スタートアップへの資金調達の増加は、遺伝子検査関連の研究をさらに後押ししています。

DNA増殖技術の台頭

この市場を牽引しているのは、主にDNA増殖技術の改良が急速に進んでいることです。ループ媒介増幅に関連する技術の進歩により、核酸配列に基づく増幅（NASBA）、ローリングサークル増幅（RCA）、ループ媒介等温増幅（LAMP）などの先進技術やその代替技術について多くの研究が行われています。これらの方法は、単一細胞からの簡便な増殖、速い増幅速度論、コストのかかるヒートサイクルが不要などの利点があるため、人気が高まっています。これらの要素は、この市場で販売される商品に対する消費者の需要を高め、結果として有機的な収益成長を後押しすると予想されます。

市場セグメンテーション

用途別では創薬が大きなシェアを占める

がんや遺伝性疾患を含む疾患に関する研究の拡大、技術開発の進展、新たな創薬技術の導入が、この市場セグメントの高シェアの主な要因となっています。例えば、2021年7月、Eli LillyとVerge Genomicsは、筋萎縮性側索硬化症（ALS）治療のための新薬を研究・創出するためのパートナーシップを締結しました。この新たな提携により、ヴァージは深刻な遺伝性疾患の治療法を開発するため、全人類を対象とした人工知能（AI）主導の創薬・開発プラットフォームを開発しました。この新プラットフォームは、臨床試験や市場投入に活用されています。

地域別展望

世界の全ゲノム増幅市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されます。

ヘルスケア分野に投資するアジア太平洋諸国

  • アジア太平洋市場は、より良いヘルスケア・インフラを整備するための政府の積極的な取り組みにより成長しています。
  • 中国やインドなどの国々における市場拡大は、熟練労働力の容易な入手を後押しし、ゲノム・分子診断分野における研究努力を増大させています。

北米が主要市場シェアを占める

同地域には強固なバイオテクノロジー研究開発インフラが存在し、数多くの遺伝子研究イニシアチブが存在することが、同地域市場の高シェアの主な要因となっています。さらに、遺伝子増幅ソリューション（キット、試薬、機器）の製造・販売に携わる企業のかなりの部分が米国に本社を置いています。この要素も、この地域の高収益に一役買っています。これとは別に、老年人口の増加と地域人口の高いヘルスケア支出が、地域市場の需要をさらに後押ししています。

世界の全ゲノム増幅市場に参入している主要企業には、GEヘルスケア、イルミナ、アジレント・テクノロジー、メルクKGaA、サーモフィッシャーサイエンティフィックなどがあります。市場競争力を維持するため、各社は提携やM&Aなどの戦略を適用し、事業拡大や製品開拓にますます力を入れています。例えば、ホロジックは2021年4月、ニアペイシェント、急性期医療診断検査のイノベーターであるモビディアグを約7億9,500万米ドルで買収しました。この買収により、同社は診断検査市場での足跡を拡大するつもりです。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主要業界動向
    • 市場推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Agilent Technologies Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • GE Healthcare
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Illumina Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Thermo Fisher Scientific Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 全ゲノム増幅の世界市場：製品タイプ別
    • 機器
    • キット・試薬
    • サービス
  • 全ゲノム増幅の世界市場：用途別
    • 創薬と医薬品開発
    • 疾病診断
    • 農業
    • 獣医学研究
    • 科学捜査
    • その他（精密医療）
  • 全ゲノム増幅の世界市場：エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • 受託研究機関
    • 学術機関
    • その他（病院・クリニック）

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第6章 企業プロファイル

  • 23&Me Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Luminex Corp.
  • Merck KGaA
  • Myriad Genetics Inc.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California Inc.
  • PerkinElmer Inc.
  • Promega Corp.
  • Qiagen NV
  • Quest Diagnostics
  • Silicon Biosystems
  • Takara Bio Inc.
  • Vazyme Biotech Co. Ltd.
図表

LIST OF TABLES

  • 1. Global Whole Genome Amplification Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 2. Global Whole Genome Amplification Instruments Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 3. Global Whole Genome Amplification Kits & Reagents Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 4. Global Whole Genome Amplification Services Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 5. Global Whole Genome Amplification Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 6. Global Whole Genome Amplification For Drug Discovery And Development Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 7. Global Whole Genome Amplification For Disease Diagnosis Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 8. Global Whole Genome Amplification For Agriculture Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 9. Global Whole Genome Amplification For Veterinary Research Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 10. Global Whole Genome Amplification For Forensics Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 11. Global Whole Genome Amplification For Other Applications Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 12. Global Whole Genome Amplification Market Research And Analysis By End-User, 2023-2031 ($ Million)
  • 13. Global Whole Genome Amplification For Pharma And Biotech Companies Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 14. Global Whole Genome Amplification For Contract Research Organizations Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 15. Global Whole Genome Amplification For Academic Institutes Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 16. Global Whole Genome Amplification For Other End-Users Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 17. Global Whole Genome Amplification Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 18. North American Whole Genome Amplification Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 19. North American Whole Genome Amplification Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 20. North American Whole Genome Amplification Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 21. North American Whole Genome Amplification Market Research And Analysis By End-User, 2023-2031 ($ Million)
  • 22. European Whole Genome Amplification Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 23. European Whole Genome Amplification Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 24. European Whole Genome Amplification Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 25. European Whole Genome Amplification Market Research And Analysis By End-User, 2023-2031 ($ Million)
  • 26. Asia-Pacific Whole Genome Amplification Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 27. Asia-Pacific Whole Genome Amplification Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 28. Asia-Pacific Whole Genome Amplification Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 29. Asia-Pacific Whole Genome Amplification Market Research And Analysis By End-User, 2023-2031 ($ Million)
  • 30. Rest Of The World Whole Genome Amplification Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 31. Rest Of The World Whole Genome Amplification Market Research And Analysis By Product Type, 2023-2031 ($ Million)
  • 32. Rest Of The World Whole Genome Amplification Market Research And Analysis By Application, 2023-2031 ($ Million)
  • 33. Rest Of The World Whole Genome Amplification Market Research And Analysis By End-User, 2023-2031 ($ Million)

LIST OF FIGURES

  • 1. Global Whole Genome Amplification Market Share By Product Type, 2023 Vs 2031 (%)
  • 2. Global Whole Genome Amplification Instruments Market Share By Region, 2023 Vs 2031 (%)
  • 3. Global Whole Genome Amplification Kits & Reagents Market Share By Region, 2023 Vs 2031 (%)
  • 4. Global Whole Genome Amplification Services Market Share By Region, 2023 Vs 2031 (%)
  • 5. Global Whole Genome Amplification Market Share By Application, 2023 Vs 2031 (%)
  • 6. Global Whole Genome Amplification For Drug Discovery And Development Market Share By Region, 2023 Vs 2031 (%)
  • 7. Global Whole Genome Amplification For Disease Diagnosis Market Share By Region, 2023 Vs 2031 (%)
  • 8. Global Whole Genome Amplification For Agriculture Market Share By Region, 2023 Vs 2031 (%)
  • 9. Global Whole Genome Amplification For Veterinary Research Market Share By Region, 2023 Vs 2031 (%)
  • 10. Global Whole Genome Amplification For Forensics Market Share By Region, 2023 Vs 2031 (%)
  • 11. Global Whole Genome Amplification For Other Applications Market Share By Region, 2023 Vs 2031 (%)
  • 12. Global Whole Genome Amplification Market Share By End-User, 2023 Vs 2031 (%)
  • 13. Global Whole Genome Amplification For Pharma And Biotech Companies Market Share By Region, 2023 Vs 2031 (%)
  • 14. Global Whole Genome Amplification For Contract Research Organizations Market Share By Region, 2023 Vs 2031 (%)
  • 15. Global Whole Genome Amplification For Academic Institutes Market Share By Region, 2023 Vs 2031 (%)
  • 16. Global Whole Genome Amplification For Other End-Users Market Share By Region, 2023 Vs 2031 (%)
  • 17. Global Whole Genome Amplification Market Share By Region, 2023 Vs 2031 (%)
  • 18. US Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 19. Canada Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 20. UK Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 21. France Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 22. Germany Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 23. Italy Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 24. Spain Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 25. Rest Of Europe Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 26. India Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 27. China Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 28. Japan Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 29. South Korea Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 30. Rest Of Asia-Pacific Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 31. Latin America Whole Genome Amplification Market Size, 2023-2031 ($ Million)
  • 32. Middle East And Africa Whole Genome Amplification Market Size, 2023-2031 ($ Million)
目次
Product Code: OMR2028631

Global Whole Genome Amplification Market Size, Share & Trends Analysis Report by Product Type (Instruments, Kits and Reagents, and Services), by Application (Drug Discovery and Development, Disease Diagnosis, Agriculture, Veterinary Research, Forensics, and Others), and by End-User (Pharma and Biotech Companies, Contract Research Organizations, Academic Institutes, and Others) Forecast Period (2024-2031)

Whole genome amplification market is anticipated to grow at a CAGR of 7.3% during the forecast period (2024-2031). Whole genome amplification is the process of amplifying the entire genome from nanogram quantities of DNA to microgram quantities of amplified products. It has been used to amp up material from a single DNA cell and is an important tool for the preservation of small samples of DNA products. Numerous techniques, such as primer extension preamplification, multiple displacement amplification, and degenerate oligonucleotide PCR, have been developed for whole genome amplification.

Market Dynamics

Growing demand for research and development in genetic testing

One of the main factors driving market expansion is the increasing requirement for research and development in the fields of genetic testing, genomics, biological research, and molecular diagnostics. In January 2024, Sano Genetics, a software company accelerating precision medicine research raised $11.4 million in new funding, led by Plural with participation from existing investors including MMC Ventures, Episode 1 and Seedcamp. The growing funding for genetic testing startups is further aiding the research related to genetic testing.

Rising DNA multiplication technologies

The market is driven primarily by the rapidly growing array of improved DNA multiplication technologies. Due to the advances in technology related to loop-mediated amplification, a great deal of research has been done on advanced technologies and their alternatives, including Nucleic Acid Sequence Based Amplification (NASBA), Rolling Circle Amplification (RCA), and Loop-Mediated Isothermal Amplification (LAMP). These methods are becoming more popular due to their benefits, which include facile multiplication from a single cell, fast amplification kinetics, and no need for costly heat cycles. These elements are anticipated to increase consumer demand for the goods sold in this market and, as a result, boost organic revenue growth.

Market Segmentation

  • Based on product type, the market is segmented into instruments, kits and reagents, and services.
  • Based on application, the market is segmented into drug discovery and development, disease diagnosis, agriculture, veterinary research, forensics, and others including precision medicine.
  • Based on end-user, the market is segmented into pharma and biotech companies, contract research organizations, academic institutes, and others including hospitals & clinics.

Drug Discovery Holds Major Share Based on Application

The growing research on diseases including cancer and genetic disorders, increasing technological developments, and new drug discovery techniques implemented are key contributors to the high share of this market segment. For instance, in July 2021, Eli Lilly and Verge Genomics entered a partnership to research and create new drugs for the treatment of amyotrophic lateral sclerosis (ALS). With this new partnership, Verge developed an all-in-human, artificial-intelligence (AI)-driven drug discovery and development platform to develop treatments for serious genetic diseases. This new platform is being used to advance them into clinical trials and markets.

Regional Outlook

The global whole genome amplification market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific countries to invest in healthcare sector

  • The Asia-Pacific market is growing as it has favorable government initiatives to develop better healthcare infrastructure.
  • The market expansion in nations, such as China and India, has boosted the easy availability of skilled labor and increased research efforts in the field of genomics and molecular diagnostics.

North America Holds Major Market Share

The presence of robust biotechnology R&D infrastructure in the region along with the significant presence of numerous genetic research initiatives are key contributors to the high share of the regional market. Furthermore, a sizable portion of businesses involved in the production and marketing of gene amplification solutions that are kits, reagents, and instruments have their headquarters in the US. This element also played a role in the region's high revenue generation. Apart from this, the growing geriatric population and the high healthcare expenditure of the regional population are further aiding the demand for the regional market.

The major companies serving the global whole genome amplification market include GE Healthcare, Illumina, Inc., Agilent Technologies, Inc., Merck KGaA, and Thermo Fisher Scientific Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions among others to stay competitive in the market. For instance, in April 2021, Hologic acquired Mobidiag, an innovator in near-patient, acute care diagnostic testing, for approximately $795 million. With this acquisition, the company intends to expand its footprint in the diagnostic testing market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Industry Trends
    • 2.2.2. Market Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Agilent Technologies Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GE Healthcare
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Illumina Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Thermo Fisher Scientific Inc.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Whole Genome Amplification Market by Product Type
    • 4.1.1. Instruments
    • 4.1.2. Kits & Reagents
    • 4.1.3. Services
  • 4.2. Global Whole Genome Amplification Market by Application
    • 4.2.1. Drug Discovery and Development
    • 4.2.2. Disease Diagnosis
    • 4.2.3. Agriculture
    • 4.2.4. Veterinary Research
    • 4.2.5. Forensics
    • 4.2.6. Others (Precision Medicine)
  • 4.3. Global Whole Genome Amplification Market by End-User
    • 4.3.1. Pharma and Biotech Companies
    • 4.3.2. Contract Research Organizations
    • 4.3.3. Academic Institutes
    • 4.3.4. Others (Hospitals & Clinics)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World
    • 5.4.1. Latin America
    • 5.4.2. Middle East & Africa

6. Company Profiles

  • 6.1. 23&Me Inc.
  • 6.2. Bio-Rad Laboratories, Inc.
  • 6.3. Danaher Corp.
  • 6.4. Eurofins Scientific SE
  • 6.5. F. Hoffmann-La Roche Ltd.
  • 6.6. Luminex Corp.
  • 6.7. Merck KGaA
  • 6.8. Myriad Genetics Inc.
  • 6.9. Oxford Nanopore Technologies
  • 6.10. Pacific Biosciences of California Inc.
  • 6.11. PerkinElmer Inc.
  • 6.12. Promega Corp.
  • 6.13. Qiagen NV
  • 6.14. Quest Diagnostics
  • 6.15. Silicon Biosystems
  • 6.16. Takara Bio Inc.
  • 6.17. Vazyme Biotech Co. Ltd.